Cancer stem cell hypotheses: Impact on modern molecular physiology and pharmacology research

Journal of Biosciences

Volumn 36, Issue 5, 2011, Pages 957-961

  Pantic, Igor ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

CD133; CD34; Hedgehog; Notch; Wnt

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; INTERLEUKIN 8; ANTINEOPLASTIC AGENT; TUMOR MARKER;

BIOCHEMISTRY; CANCER; CELL ORGANELLE; DRUG; EXPERIMENTAL STUDY; HETEROGENEITY; HYPOTHESIS TESTING; PHYSIOLOGY; RESEARCH WORK;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BRAIN CANCER; CANCER INHIBITION; CANCER RESEARCH; CANCER STEM CELL; CELL POPULATION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE RESPONSE; MOLECULAR BIOLOGY; NONHUMAN; REVIEW; ANIMAL; DRUG EFFECT; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALIA; ERINACEIDAE;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858710596     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-011-9155-5     Document Type: Review

References (34)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF 2003 Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 3983-3988
2. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN 2006 Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (London) 444 756-760
3. Barabé F, Kennedy JA, Hope KJ and Dick JE 2007 Modeling the initiation and progression of human acute leukemia in mice. Science 316 600-604
4. Becker AJ, McCulloch EA and Till JE 1963 Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature (London) 197 452-454
5. Bomken S, Fiser K, Heidenreich O and Vormoor J 2010 Understanding the cancer stem cell. Br. J. Cancer 103 439-445
6. Bonnet D and Dick JE 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 730-737
7. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, et al. 2009 Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 69 1302-1313
8. de Sousa EM, Vermeulen L, Richel D and Medema JP 2011 Targeting Wnt signaling in colon cancer stem cells. Clin. Cancer Res. 17 647-653
9. Fábián A, Barok M, Vereb G and Szöllosi J 2009 Die hard: are cancer stem cells the Bruce Willises of tumor biology? Cytometry A 75 67-74
10. Fillmore CM, Gupta PB, Rudnick JA, Caballero S, Keller PJ, Lander ES and Kuperwasser C 2010 Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc. Natl. Acad. Sci. USA 107 21737-21742
11. Folkins C, Man S, Xu P, Shaked Y, Hicklin DJ and Kerbel RS 2007 Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res. 67 3560-3564
12. Furth J and Kahn MC 1937 The transmission of leukaemia of mice with a single cell. Am. J. Cancer. 31 276-282
13. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, et al. 2007 ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1 555-567
14. Gupta PB, Chaffer CL and Weinberg RA 2009 Cancer stem cells: mirage or reality? Nat. Med. 15 1010-1012
15. Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS and Jordan CT 2005 The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105 4163-4169
16. Ichim CV and Wells RA 2006 First among equals: the cancer cell hierarchy Leuk. Lymphoma 47 2017-2027
17. Irvin DK, Jouanneau E, Duvall G, Zhang XX, Zhai Y, Sarayba D, Seksenyan A, Panwar A, Black KL and Wheeler CJ 2010 T cells enhance stem-like properties and conditional malignancy in gliomas. PloS One 5 e10974
18. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F and Dick JE 2006 Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12 1167-1174
19. Kelly PN, Dakic A, Adams JM, Nutt SL and Strasser A 2007 Tumor growth need not be driven by rare cancer stem cells. Science 317 337
20. Kennedy JA, Barabé F, Poeppl AG, Wang JC and Dick JE 2007 Comment on "Tumor growth need not be driven by rare cancer stem cells". Science 318 1722
21. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and Dick JE 1994 A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (London) 367 645-648
22. La Porta C 2009 Cancer stem cells: lessons from melanoma. Stem Cell Rev. 5 61-65
23. McCulloch EA and Till JE 1960 The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice. Radiation Res. 13 115-125
24. Nowell PC 1976 The clonal evolution of tumor cell populations. Science 194 23-28
25. O'Brien CA, Pollett A, Gallinger S and Dick JE 2007 A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (London) 445 106-110
26. Peñuelas S, Anido J, Prieto-Sánchez RM, Folch G, Barba I, Cuartas I, García-Dorado D, Poca MA, et al. 2009 TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15 315-327
27. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C and De Maria R 2007 Identification and expansion of human colon-cancer- initiating cells. Nature (London) 445 111-115
28. Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, Keefer C, Swider CR, Strzelecki AC, et al. 2011 Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice. J. Clin. Invest. 121 384-395
29. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, et al. 2008 Identification of cells initiating human melanomas. Nature(London) 451 345-349
30. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB 2004 Identification of human brain tumour initiating cells. Nature (London) 432 396-401
31. Takebe N, Harris PJ, Warren RQ and Ivy SP 2011 Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat. Rev. Clin. Oncol. 8 97-106
32. Till JE, McCulloch EA and Siminovitch L 1964 A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc. Natl. Acad. Sci. USA 51 29-36
33. Visvader JE and Lindeman GJ 2008 Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8 755-768
34. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV and Varticovski L 2008 Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res. 10 R10